Regulation of Aortic Wall Structure by the Renin-Angiotensin System in Wistar Rats

The effects of long-term angiotensin-converting enzyme (ACE) inhibition, angiotensin II (AT1)-receptor blockade, calcium-entry blockade, or cyclosporin A treatment on rat aortic wall structure were investigated to determine the role of the renin-angiotensin system in the physiologic regulation of va...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiovascular pharmacology 1998-01, Vol.31 (1), p.31-38
Hauptverfasser: Unkelbach, Manfred, Auch-Schwelk, Wolfgang, Unkelbach, Ellen, Jautzke, Günter, Fleck, Eckart
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 38
container_issue 1
container_start_page 31
container_title Journal of cardiovascular pharmacology
container_volume 31
creator Unkelbach, Manfred
Auch-Schwelk, Wolfgang
Unkelbach, Ellen
Jautzke, Günter
Fleck, Eckart
description The effects of long-term angiotensin-converting enzyme (ACE) inhibition, angiotensin II (AT1)-receptor blockade, calcium-entry blockade, or cyclosporin A treatment on rat aortic wall structure were investigated to determine the role of the renin-angiotensin system in the physiologic regulation of vascular structure in vivo. Groups of 15 Wistar rats were treated for 6 weeks either with the ACE inhibitors lisinopril or fosinopril or with the AT1-antagonists D 8731 or losartan (each 10 mg/kg/day) or with the calcium antagonist isradipine, 60 mg/kg/day, or cyclosporin A, 15 mg/kg/day, or a combination of cyclosporin with one of the vasodilators. Media thickness, vascular smooth-muscle cell density, and intima thickening were measured in histologic sections of the abdominal aorta. In addition, aortic contractility and heart weight were determined. Long-term ACE inhibition, AT1-receptor blockade, and calcium-entry blockade reduced aortic media thickness and increased media smooth-muscle cell density. Only ACE inhibition significantly reduced the extent of intima lesions. Media thickness correlated well with the maximal aortic contraction to phenylephrine and serotonin but not to angiotensin II. ACE inhibition and AT1-receptor blockade decreased heart weight, whereas calcium antagonism increased it. Cyclosporin treatment was without effect on any of these parameters. The data demonstrate a significant long-term influence of the renin-angiotensin system on aortic wall structure and function in Wistar rats.
doi_str_mv 10.1097/00005344-199801000-00005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79674638</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79674638</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4345-dde61a04efa0357881a7aa24bf0063af377ac9978d42ecbd35800d61a53e92cf3</originalsourceid><addsrcrecordid>eNp1UU1P5DAMjVasYJjlJ6yUA-JWSBq3aY8jxJeEhDTsimPkSV0mkGkhSYXm31OY7tzWF9vvPdvSM2NcinMpan0hxigUQCbruhJy7LJv6AebyUKpDESuDthMyFJkOUB5xI5jfBFCQqHLQ3ZYQ1HmGmZsuaTnwWNyfcf7li_6kJzlT-g9f0xhsGkIxFdbntbEl9S5Llt0z65P1EXX8cdtTLThY_XkYsLAl5jiL_azRR_pZMpz9vf66s_lbXb_cHN3ubjPLCgosqahUqIAalGoQleVRI2Yw6oVolTYKq3R1rWuGsjJrhpVVEI040ihqM5tq-bsbLf3LfTvA8VkNi5a8h476ododF1qKFU1Cqud0IY-xkCteQtug2FrpDBfdpp_dpq9nRM0Z7-nG8NqQ81-cPJv5E8nHqNF3wbsrIt7WS6lBvhaAzvZR-8Thfjqhw8KZk3o09r875nqE3Tri_U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79674638</pqid></control><display><type>article</type><title>Regulation of Aortic Wall Structure by the Renin-Angiotensin System in Wistar Rats</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Unkelbach, Manfred ; Auch-Schwelk, Wolfgang ; Unkelbach, Ellen ; Jautzke, Günter ; Fleck, Eckart</creator><creatorcontrib>Unkelbach, Manfred ; Auch-Schwelk, Wolfgang ; Unkelbach, Ellen ; Jautzke, Günter ; Fleck, Eckart</creatorcontrib><description>The effects of long-term angiotensin-converting enzyme (ACE) inhibition, angiotensin II (AT1)-receptor blockade, calcium-entry blockade, or cyclosporin A treatment on rat aortic wall structure were investigated to determine the role of the renin-angiotensin system in the physiologic regulation of vascular structure in vivo. Groups of 15 Wistar rats were treated for 6 weeks either with the ACE inhibitors lisinopril or fosinopril or with the AT1-antagonists D 8731 or losartan (each 10 mg/kg/day) or with the calcium antagonist isradipine, 60 mg/kg/day, or cyclosporin A, 15 mg/kg/day, or a combination of cyclosporin with one of the vasodilators. Media thickness, vascular smooth-muscle cell density, and intima thickening were measured in histologic sections of the abdominal aorta. In addition, aortic contractility and heart weight were determined. Long-term ACE inhibition, AT1-receptor blockade, and calcium-entry blockade reduced aortic media thickness and increased media smooth-muscle cell density. Only ACE inhibition significantly reduced the extent of intima lesions. Media thickness correlated well with the maximal aortic contraction to phenylephrine and serotonin but not to angiotensin II. ACE inhibition and AT1-receptor blockade decreased heart weight, whereas calcium antagonism increased it. Cyclosporin treatment was without effect on any of these parameters. The data demonstrate a significant long-term influence of the renin-angiotensin system on aortic wall structure and function in Wistar rats.</description><identifier>ISSN: 0160-2446</identifier><identifier>EISSN: 1533-4023</identifier><identifier>DOI: 10.1097/00005344-199801000-00005</identifier><identifier>PMID: 9456274</identifier><identifier>CODEN: JCPCDT</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott-Raven Publishers</publisher><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Animals ; Antihypertensive agents ; Antirheumatic Agents - pharmacology ; Aorta - drug effects ; Aorta - physiology ; Biological and medical sciences ; Body Weight - drug effects ; Cardiovascular system ; Cyclosporine - pharmacology ; Male ; Medical sciences ; Muscle Contraction - drug effects ; Muscle, Smooth, Vascular - drug effects ; Muscle, Smooth, Vascular - physiology ; Organ Size - drug effects ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar ; Receptors, Angiotensin - drug effects ; Renin-Angiotensin System - drug effects ; Renin-Angiotensin System - physiology ; Tunica Intima - drug effects ; Vasoconstrictor Agents - pharmacology</subject><ispartof>Journal of cardiovascular pharmacology, 1998-01, Vol.31 (1), p.31-38</ispartof><rights>Lippincott-Raven Publishers</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4345-dde61a04efa0357881a7aa24bf0063af377ac9978d42ecbd35800d61a53e92cf3</citedby><cites>FETCH-LOGICAL-c4345-dde61a04efa0357881a7aa24bf0063af377ac9978d42ecbd35800d61a53e92cf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;NEWS=n&amp;CSC=Y&amp;PAGE=fulltext&amp;D=ovft&amp;AN=00005344-199801000-00005$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,778,782,4012,4597,27906,27907,27908,65214</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2117445$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9456274$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Unkelbach, Manfred</creatorcontrib><creatorcontrib>Auch-Schwelk, Wolfgang</creatorcontrib><creatorcontrib>Unkelbach, Ellen</creatorcontrib><creatorcontrib>Jautzke, Günter</creatorcontrib><creatorcontrib>Fleck, Eckart</creatorcontrib><title>Regulation of Aortic Wall Structure by the Renin-Angiotensin System in Wistar Rats</title><title>Journal of cardiovascular pharmacology</title><addtitle>J Cardiovasc Pharmacol</addtitle><description>The effects of long-term angiotensin-converting enzyme (ACE) inhibition, angiotensin II (AT1)-receptor blockade, calcium-entry blockade, or cyclosporin A treatment on rat aortic wall structure were investigated to determine the role of the renin-angiotensin system in the physiologic regulation of vascular structure in vivo. Groups of 15 Wistar rats were treated for 6 weeks either with the ACE inhibitors lisinopril or fosinopril or with the AT1-antagonists D 8731 or losartan (each 10 mg/kg/day) or with the calcium antagonist isradipine, 60 mg/kg/day, or cyclosporin A, 15 mg/kg/day, or a combination of cyclosporin with one of the vasodilators. Media thickness, vascular smooth-muscle cell density, and intima thickening were measured in histologic sections of the abdominal aorta. In addition, aortic contractility and heart weight were determined. Long-term ACE inhibition, AT1-receptor blockade, and calcium-entry blockade reduced aortic media thickness and increased media smooth-muscle cell density. Only ACE inhibition significantly reduced the extent of intima lesions. Media thickness correlated well with the maximal aortic contraction to phenylephrine and serotonin but not to angiotensin II. ACE inhibition and AT1-receptor blockade decreased heart weight, whereas calcium antagonism increased it. Cyclosporin treatment was without effect on any of these parameters. The data demonstrate a significant long-term influence of the renin-angiotensin system on aortic wall structure and function in Wistar rats.</description><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Antihypertensive agents</subject><subject>Antirheumatic Agents - pharmacology</subject><subject>Aorta - drug effects</subject><subject>Aorta - physiology</subject><subject>Biological and medical sciences</subject><subject>Body Weight - drug effects</subject><subject>Cardiovascular system</subject><subject>Cyclosporine - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Muscle, Smooth, Vascular - physiology</subject><subject>Organ Size - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Angiotensin - drug effects</subject><subject>Renin-Angiotensin System - drug effects</subject><subject>Renin-Angiotensin System - physiology</subject><subject>Tunica Intima - drug effects</subject><subject>Vasoconstrictor Agents - pharmacology</subject><issn>0160-2446</issn><issn>1533-4023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UU1P5DAMjVasYJjlJ6yUA-JWSBq3aY8jxJeEhDTsimPkSV0mkGkhSYXm31OY7tzWF9vvPdvSM2NcinMpan0hxigUQCbruhJy7LJv6AebyUKpDESuDthMyFJkOUB5xI5jfBFCQqHLQ3ZYQ1HmGmZsuaTnwWNyfcf7li_6kJzlT-g9f0xhsGkIxFdbntbEl9S5Llt0z65P1EXX8cdtTLThY_XkYsLAl5jiL_azRR_pZMpz9vf66s_lbXb_cHN3ubjPLCgosqahUqIAalGoQleVRI2Yw6oVolTYKq3R1rWuGsjJrhpVVEI040ihqM5tq-bsbLf3LfTvA8VkNi5a8h476ododF1qKFU1Cqud0IY-xkCteQtug2FrpDBfdpp_dpq9nRM0Z7-nG8NqQ81-cPJv5E8nHqNF3wbsrIt7WS6lBvhaAzvZR-8Thfjqhw8KZk3o09r875nqE3Tri_U</recordid><startdate>199801</startdate><enddate>199801</enddate><creator>Unkelbach, Manfred</creator><creator>Auch-Schwelk, Wolfgang</creator><creator>Unkelbach, Ellen</creator><creator>Jautzke, Günter</creator><creator>Fleck, Eckart</creator><general>Lippincott-Raven Publishers</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199801</creationdate><title>Regulation of Aortic Wall Structure by the Renin-Angiotensin System in Wistar Rats</title><author>Unkelbach, Manfred ; Auch-Schwelk, Wolfgang ; Unkelbach, Ellen ; Jautzke, Günter ; Fleck, Eckart</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4345-dde61a04efa0357881a7aa24bf0063af377ac9978d42ecbd35800d61a53e92cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Antihypertensive agents</topic><topic>Antirheumatic Agents - pharmacology</topic><topic>Aorta - drug effects</topic><topic>Aorta - physiology</topic><topic>Biological and medical sciences</topic><topic>Body Weight - drug effects</topic><topic>Cardiovascular system</topic><topic>Cyclosporine - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Muscle, Smooth, Vascular - physiology</topic><topic>Organ Size - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Angiotensin - drug effects</topic><topic>Renin-Angiotensin System - drug effects</topic><topic>Renin-Angiotensin System - physiology</topic><topic>Tunica Intima - drug effects</topic><topic>Vasoconstrictor Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Unkelbach, Manfred</creatorcontrib><creatorcontrib>Auch-Schwelk, Wolfgang</creatorcontrib><creatorcontrib>Unkelbach, Ellen</creatorcontrib><creatorcontrib>Jautzke, Günter</creatorcontrib><creatorcontrib>Fleck, Eckart</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiovascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Unkelbach, Manfred</au><au>Auch-Schwelk, Wolfgang</au><au>Unkelbach, Ellen</au><au>Jautzke, Günter</au><au>Fleck, Eckart</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of Aortic Wall Structure by the Renin-Angiotensin System in Wistar Rats</atitle><jtitle>Journal of cardiovascular pharmacology</jtitle><addtitle>J Cardiovasc Pharmacol</addtitle><date>1998-01</date><risdate>1998</risdate><volume>31</volume><issue>1</issue><spage>31</spage><epage>38</epage><pages>31-38</pages><issn>0160-2446</issn><eissn>1533-4023</eissn><coden>JCPCDT</coden><abstract>The effects of long-term angiotensin-converting enzyme (ACE) inhibition, angiotensin II (AT1)-receptor blockade, calcium-entry blockade, or cyclosporin A treatment on rat aortic wall structure were investigated to determine the role of the renin-angiotensin system in the physiologic regulation of vascular structure in vivo. Groups of 15 Wistar rats were treated for 6 weeks either with the ACE inhibitors lisinopril or fosinopril or with the AT1-antagonists D 8731 or losartan (each 10 mg/kg/day) or with the calcium antagonist isradipine, 60 mg/kg/day, or cyclosporin A, 15 mg/kg/day, or a combination of cyclosporin with one of the vasodilators. Media thickness, vascular smooth-muscle cell density, and intima thickening were measured in histologic sections of the abdominal aorta. In addition, aortic contractility and heart weight were determined. Long-term ACE inhibition, AT1-receptor blockade, and calcium-entry blockade reduced aortic media thickness and increased media smooth-muscle cell density. Only ACE inhibition significantly reduced the extent of intima lesions. Media thickness correlated well with the maximal aortic contraction to phenylephrine and serotonin but not to angiotensin II. ACE inhibition and AT1-receptor blockade decreased heart weight, whereas calcium antagonism increased it. Cyclosporin treatment was without effect on any of these parameters. The data demonstrate a significant long-term influence of the renin-angiotensin system on aortic wall structure and function in Wistar rats.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Lippincott-Raven Publishers</pub><pmid>9456274</pmid><doi>10.1097/00005344-199801000-00005</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0160-2446
ispartof Journal of cardiovascular pharmacology, 1998-01, Vol.31 (1), p.31-38
issn 0160-2446
1533-4023
language eng
recordid cdi_proquest_miscellaneous_79674638
source MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Angiotensin-Converting Enzyme Inhibitors - pharmacology
Animals
Antihypertensive agents
Antirheumatic Agents - pharmacology
Aorta - drug effects
Aorta - physiology
Biological and medical sciences
Body Weight - drug effects
Cardiovascular system
Cyclosporine - pharmacology
Male
Medical sciences
Muscle Contraction - drug effects
Muscle, Smooth, Vascular - drug effects
Muscle, Smooth, Vascular - physiology
Organ Size - drug effects
Pharmacology. Drug treatments
Rats
Rats, Wistar
Receptors, Angiotensin - drug effects
Renin-Angiotensin System - drug effects
Renin-Angiotensin System - physiology
Tunica Intima - drug effects
Vasoconstrictor Agents - pharmacology
title Regulation of Aortic Wall Structure by the Renin-Angiotensin System in Wistar Rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A55%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20Aortic%20Wall%20Structure%20by%20the%20Renin-Angiotensin%20System%20in%20Wistar%20Rats&rft.jtitle=Journal%20of%20cardiovascular%20pharmacology&rft.au=Unkelbach,%20Manfred&rft.date=1998-01&rft.volume=31&rft.issue=1&rft.spage=31&rft.epage=38&rft.pages=31-38&rft.issn=0160-2446&rft.eissn=1533-4023&rft.coden=JCPCDT&rft_id=info:doi/10.1097/00005344-199801000-00005&rft_dat=%3Cproquest_cross%3E79674638%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79674638&rft_id=info:pmid/9456274&rfr_iscdi=true